Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection
Status:
Completed
Trial end date:
2017-09-27
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the effect of presatovir on nasal
respiratory syncytial virus (RSV) viral load in RSV-positive lung transplant (LT) recipients
with acute respiratory symptoms.